Organization | Valley Health System

Valley Health System Report issue

Academic/Hospital Phase 2 Phase 3

Founded: Ridgewood NJ United States

Organization Overview

First Clinical Trial

2000

NCT00482781

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2018

Timeline

NOW

Now

Alternative names

The Valley Hosptial | Valley Health System | Valley Health Systems/ The Valley Hospital | Valley Hospital, Ridgewood, NJ

Active Ingredients

Drugs in Phase 3 Trials (5)

cephalexin (keflex) (1 trial)

clindamycin (cleocin) (1 trial)

levofloxacin (levaquin) (1 trial)

polymyxin b sulfate (poly-rx) (1 trial)

sodium chloride (1 trial)

Drugs in Phase 2 Trials (2)

cisplatin (platinol) (1 trial)

etoposide (vepesid) (1 trial)

Drugs in Other Trials (1)

diphtheria-tetanus-acellular pertussis-inactivated poliovirus-haemophilus influenzae b conjugate-hepatitis b vaccine (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Heart Block (Phase 3)

Heart Failure, Systolic (Phase 3)

Infections (Phase 3)

Sick Sinus Syndrome (Phase 3)

Syncope (Phase 3)

Thymoma (Phase 2)

Thymus Neoplasms (Phase 2)

Overview

Highest Phase: Phase 3
# of Trials: 3
# of Trial APIs: 8